Artificial intelligence can predict on- and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology. The study by researchers at ...

Researchers at New York University (NYU), Columbia University, and the New York Genome Center have developed an artificial intelligence (AI) platform that can predict on- and off-target activity of ...

At the end of 2023, the FDA approved Casgevy for sickle cell disease, its first approval for a therapeutic that used the genome editing tool clustered regulatory interspaced palindromic repeats ...

Scientists at CRISPR Therapeutics have compared three commonly used methods to detect off-target gene editing activity of the CRISPR-Cas9 machinery and found them to be equally adept, although each ...

Investors with a lot of money to spend have taken a bullish stance on Target (NYSE:TGT). And retail traders should know. We noticed this today when the trades showed up on publicly available options ...